COPD Trial, Recruiting NCT06678191 Sponsor: Chiesi Hungary Ltd. Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06678191
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with asthma by a doctor (following standard medical guidelines) and have been receiving treatment for it for at least 3 years
  • You are 18 years of age or older and receive your asthma care on an outpatient basis (not in a hospital)
  • Your asthma is not well controlled according to your doctor, even though you are already using a combination of strong inhaled medications (confirm with trial site for exact medications)
  • You have had at least one asthma flare-up in the past 12 months that required steroid tablets or an injection to treat
  • Your asthma symptom score is 15 or below on a standard questionnaire called the ACT (Asthma Control Test)
  • Your lung function test (a breathing test called FEV1) shows your lungs are working at less than 80% of the expected level
  • You have recently switched to (or are switching to) the study medication, Trimbow 172/5/9 μg inhaler, within one week before or on the day you join the study
  • You have read and signed a consent form agreeing to take part in the study

Who may not be able to join:

  • You have taken part in another clinical trial in the past 30 days
  • You were hospitalised due to an asthma attack in the past 4 weeks
  • You have another lung or breathing condition (other than asthma or COPD) that could affect how the treatment works, or another serious health issue that might make it hard to follow the treatment plan
  • You are currently taking steroid tablets or steroid injections on a regular, ongoing basis at certain doses (confirm with trial site for exact doses)
  • You rely on continuous oxygen therapy at home
  • You have been diagnosed with any type of cancer in the last 5 years
  • You have active tuberculosis (TB) or have had it in the past
  • You have used any biologic medicines (a type of specialist injection treatment) for your asthma in the past 12 months
  • You meet any of the standard reasons listed in the official prescribing information for Trimbow 172/5/9 μg that would prevent its use (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +36309788085

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chiesi Hungary Ltd.
Registry
ClinicalTrials.gov
Start date
24 October 2024
Est. completion
31 October 2026

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Asthma control Test; Asthma control Test 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov